Pursuant to Regulation 30, 33 and any other provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sai Life Sciences has informed that, the Board of Directors of the Company, at its meeting held on Tuesday, 13 May 2025, considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company and noted the Audit Report of the Statutory Auditors, Deloitte Haskins & Sells LLP for the quarter and financial year ended 31 March 2025. A copy of the same are enclosed as Annexure. The Meeting of the Board of Directors was duly commenced at 6:30 pm (IST) and concluded at 10:30 pm (IST).
The above information is a part of company’s filings submitted to BSE.
